Role of α1D-adrenoceptors in vascular wall hypertrophy during angiotensin II-induced hypertension

2015 ◽  
Vol 35 (3) ◽  
pp. 17-31 ◽  
Author(s):  
I. A. Gallardo-Ortíz ◽  
S. N. Rodríguez-Hernández ◽  
J. J. López-Guerrero ◽  
L. Del Valle-Mondragón ◽  
P. López-Sánchez ◽  
...  
Hypertension ◽  
2013 ◽  
Vol 62 (3) ◽  
pp. 564-571 ◽  
Author(s):  
Bing S. Huang ◽  
Roselyn A. White ◽  
Monir Ahmad ◽  
Frans H.H. Leenen

2003 ◽  
Vol 1 (3) ◽  
pp. 113-117 ◽  
Author(s):  
M. Myronidou ◽  
B. Kokkas ◽  
A. Kouyoumtzis ◽  
N. Gregoriadis ◽  
A. Lourbopoulos ◽  
...  

In these studies we investigated if losartan, an AT1- receptor blocker has any beneficial effect on NO production from the bovine aortic preparations in vitro while under stimulation from angiotensin II. Experiments were performed on intact specimens of bovine thoracic aorta, incubated in Dulbeco's MOD medium in a metabolic shaker for 24 hours under 95 % O2 and 5 % CO2 at a temperature of 37°C. We found that angiotensin II 1nM−10 μM does not exert any statistically significant action on NO production. On the contrary, angiotensin II 10nM increases the production of NO by 58.14 % (from 12.16 + 2.9 μm/l to 19.23 + 4.2 μm/l in the presence of losartan 1nM (P<0.05). Nitric oxide levels depend on both rate production and rate catabolism or chemical inactivation. Such an equilibrium is vital for the normal function of many systems including the cardiovascular one. The above results demonstrate that the blockade of AT1-receptors favors the biosynthesis of NO and indicate the protective role of losartan on the vascular wall.


2016 ◽  
Vol 78 ◽  
pp. 38-47 ◽  
Author(s):  
Jean F. Regal ◽  
Megan E. Strehlke ◽  
Jenna M. Peterson ◽  
Cameron R. Wing ◽  
Jordan E. Parker ◽  
...  

1998 ◽  
Vol 16 (12) ◽  
pp. 1767-1774 ◽  
Author(s):  
Te-Chao Fang ◽  
Wann-Chu Huang

2019 ◽  
Vol 51 (4) ◽  
pp. 97-108 ◽  
Author(s):  
Xiao C. Li ◽  
Xiaowen Zheng ◽  
Xu Chen ◽  
Chunling Zhao ◽  
Dongmin Zhu ◽  
...  

The sodium (Na+)/hydrogen (H+) exchanger 3 (NHE3) and sodium-potassium adenosine triphosphatase (Na+/K+-ATPase) are two of the most important Na+ transporters in the proximal tubules of the kidney. On the apical membrane side, NHE3 primarily mediates the entry of Na+ into and the exit of H+ from the proximal tubules, directly and indirectly being responsible for reabsorbing ~50% of filtered Na+ in the proximal tubules of the kidney. On the basolateral membrane side, Na+/K+-ATPase serves as a powerful engine driving Na+ out of, while pumping K+ into the proximal tubules against their concentration gradients. While the roles of NHE3 and Na+/K+-ATPase in proximal tubular Na+ transport under in vitro conditions are well recognized, their respective contributions to the basal blood pressure regulation and angiotensin II (ANG II)-induced hypertension remain poorly understood. Recently, we have been fortunate to be able to use genetically modified mouse models with global, kidney- or proximal tubule-specific deletion of NHE3 to directly determine the cause and effect relationship between NHE3, basal blood pressure homeostasis, and ANG II-induced hypertension at the whole body, kidney and/or proximal tubule levels. The purpose of this article is to review the genetic and genomic evidence for an important role of NHE3 with a focus in the regulation of basal blood pressure and ANG II-induced hypertension, as we learned from studies using global, kidney- or proximal tubule-specific NHE3 knockout mice. We hypothesize that NHE3 in the proximal tubules is necessary for maintaining basal blood pressure homeostasis and the development of ANG II-induced hypertension.


Hypertension ◽  
2017 ◽  
Vol 70 (6) ◽  
pp. 1219-1227 ◽  
Author(s):  
Lei Wang ◽  
Ximing Wang ◽  
Helena Y. Qu ◽  
Shan Jiang ◽  
Jie Zhang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document